CD39 downregulation in chronic intervillositis of unknown etiology
- PMID: 31218404
- DOI: 10.1007/s00428-019-02598-6
CD39 downregulation in chronic intervillositis of unknown etiology
Abstract
Chronic intervillositis of unknown etiology (CIUE) is a rare placental lesion associated with infiltration of mononuclear inflammatory cells into the intervillous space, poor perinatal outcomes (intrauterine fetal demise or fetal growth restriction), and high rates of recurrence. CD39 is the ectonucleotidase that protects tissues from inflammatory stress and cell injury, which is localized on the surface of villi in normal placentas; however, its expression and role in CIUE are unknown. The aims of this retrospective study were to determine the expression of CD39 in CIUE and its significance in pregnancy outcomes. We compared the number of CD68- and CD3-positive cells, CD39 expression, and complement 4d (C4d) and fibrin deposition in placental tissues from patients with CIUE (n = 22) and gestational age-matched controls (n = 20), and between CIUE pregnancies with poor and good outcomes. The numbers of CD68- or CD3-positive cells were significantly higher (P < 0.0001), whereas CD39 expression on the surface of villi and endothelial cells of the stem villi was significantly lower in the CIUE group than that in controls (45% vs. 95%, P < 0.0001 and 77% vs. 96%, P < 0.001, respectively). C4d and fibrin deposition were also significantly increased in CIUE compared with those of controls. Furthermore, CD39 downregulation and the number of CD68 cells were strongly associated with poor pregnancy outcomes (P < 0.01 and P < 0.05, respectively), but other histological parameters (CD3, C4d, and fibrin) did not show this association. Our study suggests that CD39 downregulation is a useful marker of CIUE and is associated with poor pregnancy outcomes in patients with CIUE.
Keywords: Abortion; C4d; CD3; CD39; CD68; Chronic intervillositis of unknown etiology; Fetal growth restriction.
Similar articles
-
Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: About a series of 178 cases.Placenta. 2016 Aug;44:104-8. doi: 10.1016/j.placenta.2016.04.017. Epub 2016 May 15. Placenta. 2016. PMID: 27452445
-
Clinical outcomes in chronic intervillositis of unknown etiology.Placenta. 2020 Feb;91:19-23. doi: 10.1016/j.placenta.2020.01.001. Epub 2020 Jan 10. Placenta. 2020. PMID: 32174302
-
Complement receptor-associated CD163+/CD18+/CD11c+/CD206-/CD209- expression profile in chronic histiocytic intervillositis of the placenta.Placenta. 2019 Mar;78:23-28. doi: 10.1016/j.placenta.2019.02.007. Epub 2019 Feb 15. Placenta. 2019. PMID: 30955707
-
Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic review.Placenta. 2018 Jan;61:80-88. doi: 10.1016/j.placenta.2017.11.012. Epub 2017 Nov 23. Placenta. 2018. PMID: 29277275
-
Recurrent Chronic Intervillositis: The Diagnostic Challenge - A Case Report and Review of the Literature.J Obstet Gynaecol Can. 2019 Mar;41(3):344-347. doi: 10.1016/j.jogc.2018.05.007. Epub 2018 Nov 7. J Obstet Gynaecol Can. 2019. PMID: 30414807 Review.
Cited by
-
The Missing Role of Prenatal Diagnosis of Chronic Histiocytic Intervillositis in the Management of Growth Restricted Fetuses.Front Med (Lausanne). 2022 Feb 2;8:809315. doi: 10.3389/fmed.2021.809315. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35186976 Free PMC article. No abstract available.
-
Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.Front Immunol. 2022 Apr 22;13:825075. doi: 10.3389/fimmu.2022.825075. eCollection 2022. Front Immunol. 2022. PMID: 35529853 Free PMC article. Review.
-
Immunohistochemical Analysis of Placental Tissue of Women Infected with SARS-CoV-2 During Pregnancy-A Prospective Clinical Study.Int J Mol Sci. 2025 Aug 7;26(15):7659. doi: 10.3390/ijms26157659. Int J Mol Sci. 2025. PMID: 40806787 Free PMC article.
-
C4d deposition and CD39 downregulation in the placental infection by SARS-CoV-2.Pathol Int. 2022 Apr;72(4):267-269. doi: 10.1111/pin.13214. Epub 2022 Feb 14. Pathol Int. 2022. PMID: 35165981 Free PMC article. No abstract available.
-
Virtual crossmatching reveals upregulation of placental HLA-Class II in chronic histiocytic intervillositis.Sci Rep. 2024 Aug 12;14(1):18714. doi: 10.1038/s41598-024-69315-5. Sci Rep. 2024. PMID: 39134702 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials